John B. Sanfilippo & Son reports fiscal fourth-quarter results tomorrow, and the week's most striking signal is not the stock itself — flat on the week at $83.47 — but the sharp rebuild in short interest that preceded it.
Short sellers have been quietly adding exposure all month. Short interest has climbed roughly 23% over the past 30 days to 4.6% of the free float, with the sharpest accumulation running from August 10 through August 17. Tuesday's daily reading spiked to 557,000 shares short — the highest point in the visible history — before pulling back sharply on Tuesday to around 420,000. That single-day drop of nearly 25% likely reflects covering ahead of the print rather than a change in sentiment, and the month's trend remains clearly higher. Despite the recent accumulation, the borrow market is not signalling any stress: availability is exceptionally loose at 1,426% — meaning there are roughly fourteen shares available to borrow for every one currently shorted — and cost to borrow holds near 0.45%, barely changed on the week. The ORTEX short score has also moved — rising from the mid-36s in early August to nearly 48 on Monday before retreating to 40 — suggesting the positioning shift has been noticed.
Options positioning reinforces a mildly more cautious tone into earnings without reaching alarm levels. The put/call ratio is running at 0.33, modestly above its 20-day average of 0.25, but just 0.68 standard deviations from the mean — nothing like the defensive extremes the 52-week high of 1.79 implies are possible. Call activity still dominates, meaning the options market is not hedging aggressively into tomorrow's release.
The Street is lightly covered and relatively constructive, though analyst data is dated. Freedom Broker initiated in late June with a Hold and an $95 target — the most recent action within a reasonable window. BWS Financial has maintained a Buy rating with a $109 target since late 2025, implying roughly 30% upside from current levels. The consensus is Hold, with the mean target near $102 — about 22% above the current price. Valuation multiples look undemanding: the stock trades at roughly 17x trailing earnings, and the EV/EBITDA of around 12x has drifted slightly lower over 30 days. Factor scores are middling — dividend (66th percentile) is the standout, while the short score rank (36th) reflects the recent positioning uptick.
The dividend angle is genuinely worth flagging. JBSS declared a $1.05 special cash dividend in July, payable September 9, following a $1.50 special dividend paid in May. The pattern of recurring special dividends — the company has now issued them in 2021, 2022, and twice in 2026 — points to a management team confident in cash generation and willing to return it to shareholders directly. Institutional ownership remains concentrated: BlackRock holds nearly 13% of shares, and the founding Sanfilippo family controls a further 20%+ across multiple entities. American Century added 173,000 shares in the most recent reported quarter, the largest institutional move in the holder list. Insider data is stale (last disclosed trades were in March), so no fresh read is available on family sentiment heading into this print.
The two most recent earnings reactions offer a useful reference point. April's fiscal Q3 report produced a 3.9% next-day gain and held most of that over five days. An earlier print that quarter sparked a 6.4% day-one move with a 3.6% five-day follow-through. Both were positive, both were modest rather than explosive. Tomorrow's print is therefore less about whether JBSS can beat — it has done so consistently — and more about whether volume trends have stabilised and whether nut-cost headwinds are being managed as effectively as they were in December's standout quarter.
See the live data behind this article on ORTEX.
Open JBSS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
